EVELO BIOSCIENCES, INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f3c52533-0e3f-4777-8297-40a3f71245a5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-114.5M | 2022-01-01 – 2022-12-31 | evidence 0001694665-23-000024 |
| FY 2021 | $-122.2M | 2021-01-01 – 2021-12-31 | evidence 0001694665-22-000047 |
| FY 2020 | $-93.7M | 2020-01-01 – 2020-12-31 | evidence 0001694665-21-000037 |
| FY 2019 | $-85.5M | 2019-01-01 – 2019-12-31 | evidence 0001694665-20-000017 |
| FY 2018 | $-56.9M | 2018-01-01 – 2018-12-31 | evidence 0001694665-19-000013 |
| FY 2017 | $-28.0M | 2017-01-01 – 2017-12-31 | evidence 0001694665-19-000013 |
| FY 2016 | $-13.3M | 2016-01-01 – 2016-12-31 | evidence 0001694665-19-000013 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).